Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Bayer obtained FDA priority review for cancer drug
Bayer obtained FDA priority review for cancer drug
German drugmaker Bayer won the U.
European Medicines Agency issued its 2016 annual report
European Medicines Agency issued its 2016 annual report
The European Medicines Agency (EMA) published 2016 annual report.
Boehringer Ingelheim opened biopharmaceutical manufacturing facility in China
Boehringer Ingelheim opened biopharmaceutical manufacturing facility in China
Boehringer Ingelheim inaugurated its commercial production site for biopharmaceuticals in Zhang Jiang Hi-tech Park of Shanghai (China).
India will relaunch the inspections of API facilities in China
India will relaunch the inspections of API facilities in China
In order to ensure only quality active pharmaceutical ingredients (API) are imported from countries like China, Indian Government will be restarting inspections of drug manufacturing facilitie...
Sangamo Receives Fast Track Designation From The FDA For SB-525 Investigational Hemophilia A Gene Therapy
Sangamo Receives Fast Track Designation From The FDA For SB-525 Investigational Hemophilia A Gene Therapy
RICHMOND, Calif.
Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010
Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010
Postmarket safety events of novel pharmaceuticals and biologics occur when new safety risks are identified after initial regulatory approval of these therapeutics.
Genoa Pharmaceuticals Secures $62 Million Series A Financing, Adds to Leadership Team
Genoa Pharmaceuticals Secures $62 Million Series A Financing, Adds to Leadership Team
SEATTLE--(BUSINESS WIRE)--Genoa Pharmaceuticals, Inc.
UK patients get early access to AbbVie’s hepatitis regimen
UK patients get early access to AbbVie’s hepatitis regimen
AbbVie’s glecaprevir/pibrentasvir (G/P) has become the first treatment for chronic hepatitis C to be included in the UK’s Early Access to Medicines Scheme (EAMS).
Ardelyx reports positive phase 3 data, but shares fall hard premarket
Ardelyx reports positive phase 3 data, but shares fall hard premarket
Ardelyx says it has hit its primary endpoint and most of its secondary endpoints in a late-stage test of its IBS (with constipation) candidate tenapanor, but investors were spooked as its shar...
Will we soon have a jab for prostate cancer? Experts unveil a vaccine that could provide a cure for the disease
Will we soon have a jab for prostate cancer? Experts unveil a vaccine that could provide a cure for the disease
A vaccine that could stop prostate cancer in its tracks has been unveiled by scientists.
Teva and Active Biotech Announce CONCERTO trial of Laquinimod in RRMS Did Not Meet Primary Endpoint
Teva and Active Biotech Announce CONCERTO trial of Laquinimod in RRMS Did Not Meet Primary Endpoint
JERUSALEM & LUND, Sweden--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd.
Lilly Announces Positive Results for Three Phase 3 Studies of Galcanezumab for the Prevention of Episodic and Chronic Migraine
Lilly Announces Positive Results for Three Phase 3 Studies of Galcanezumab for the Prevention of Episodic and Chronic Migraine
INDIANAPOLIS, May 12, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand